Literature DB >> 2547512

Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers.

H zur Hausen1.   

Abstract

Infections with specific types of human papillomaviruses (HPV) have emerged as necessary but not sufficient factors for the development, at least, of the majority of cervical, vulvar, penile, and perianal cancers. Evidence has accumulated for their causal role in the induction of anogenital premalignant lesions. Genetic events underlying the mechanism of anogenital carcinogenesis have become increasingly understood. A host cell-mediated intracellular control down-regulating specific HPV genes (E6, E7) in replicating normal cells appears to be interrupted in cancer cells, probably due to structural modifications of the respective host cell genes acquired in the course of HPV DNA persistence. Since genital HPV infections are ubiquitous, cofactors which modify controlling host cell genes are likely to determine the different geographic rates of cervical cancer incidence.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2547512

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  110 in total

Review 1.  Molecular interactions of 'high risk' human papillomaviruses E6 and E7 oncoproteins: implications for tumour progression.

Authors:  Oishee Chakrabarti; Sudhir Krishna
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

2.  A simple method for elimination of unspecific amplifications in polymerase chain reaction.

Authors:  J K Sharma; V Gopalkrishna; B C Das
Journal:  Nucleic Acids Res       Date:  1992-11-25       Impact factor: 16.971

3.  The incidence of HPV in a Swedish series of invasive cervical carcinoma.

Authors:  B Hagmar; B Johansson; M Kalantari; Z Petersson; B Skyldberg; L Walaas
Journal:  Med Oncol Tumor Pharmacother       Date:  1992

4.  Meeting report. Report of meeting of Section of Clinical Immunology and Allergy, 11 March 1991.

Authors: 
Journal:  J R Soc Med       Date:  1992-02       Impact factor: 5.344

Review 5.  Human papillomavirus and tar hypothesis for squamous cell cervical cancer.

Authors:  Christina Bennett; Allen E Kuhn; Harry W Haverkos
Journal:  J Biosci       Date:  2010-09       Impact factor: 1.826

6.  Smoking increases oral HPV persistence among men: 7-year follow-up study.

Authors:  K Kero; J Rautava; K Syrjänen; J Willberg; S Grenman; S Syrjänen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-13       Impact factor: 3.267

7.  Induction of the HPV16 enhancer activity by Jun-B and c-Fos through cooperation of the promoter-proximal AP-1 site and the epithelial cell type--specific regulatory element in fibroblasts.

Authors:  K Kikuchi; A Taniguchi; S Yasumoto
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

8.  A vaccine conjugate of 'ISCAR' immunocarrier and peptide epitopes of the E7 cervical cancer-associated protein of human papillomavirus type 16 elicits specific Th1- and Th2-type responses in immunized mice in the absence of oil-based adjuvants.

Authors:  R W Tindle; S Croft; K Herd; K Malcolm; A F Geczy; T Stewart; G J Fernando
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

9.  Tetraarsenic oxide-mediated apoptosis in a cervical cancer cell line, SiHa.

Authors:  Jeong Kim; Su-Mi Bae; Dae-Seog Lim; Sun-Young Kwak; Chang-Ki Lee; Yong-Seok Lee; Il-Ju Bae; Jin-Young Yoo; Young-Joo Lee; Chong-Kook Kim; Woong-Shick Ahn
Journal:  Cancer Res Treat       Date:  2005-10-31       Impact factor: 4.679

10.  Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells.

Authors:  M von Knebel Doeberitz; T Bauknecht; D Bartsch; H zur Hausen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.